Company / Shareholders' Equity
OptimizeRx Corp Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$117.0M
FY2025
5-year range
$44.9M / $131.4M
FY2021-FY2025
Trend
-7.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from $6M in FY2018 to $131M in FY2022.
Based on SEC 10-K filings.
$117M in FY2025 with a 5-year CAGR of +21.1%.
Declined from $126M to $117M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -3.8%
- 5-Year CAGR
- +21.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +21.1%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 7.6% year-over-year.
- Peak shareholders' equity was recorded in FY2022.
- Lowest shareholders' equity in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $117.0M | -7.6% |
| FY2024 | $126.6M | +0.4% |
| FY2023 | $126.1M | -4.0% |
| FY2022 | $131.4M | +192.9% |
| FY2021 | $44.9M | +0.0% |
| FY2020 | $44.9M | +143.0% |
| FY2019 | $18.5M | +196.7% |
| FY2018 | $6.2M | -20.4% |
| FY2017 | $7.8M | -12.6% |
| FY2016 | $8.9M | +94.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026